This list is an analysis based on recent market events. It's not an investment recommendation.
Gongwin Biopharm Holdings Co., Ltd. is a clinical-stage biopharmaceutical company specializing in the development of oncology therapeutics. The company's robust pipeline features several drug candidates, including PTS302, which has successfully concluded Phase III clinical trials for lung cancer. Additionally, PTS100 is currently progressing through Phase II clinical trials for liver cancer, while PTS-02 is being developed to address adenoid cystic carcinoma, and PTS500 targets malignant pleural effusion. Established in 2014, Gongwin Biopharm is headquartered in Taipei, Taiwan.
FAQs
What is Gongwin Biopham stock price today?▼
The current price of 6617.TWO is TWD107.50 TWD — it has increased by +0.47% in the past 24 hours. Watch Gongwin Biopham stock price performance more closely on the chart.
What is Gongwin Biopham stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange Gongwin Biopham stocks are traded under the ticker 6617.TWO.
Is Gongwin Biopham stock price growing?▼
6617.TWO stock has fallen by -5.29% compared to the previous week, the month change is a -18.25% fall, over the last year Gongwin Biopham has showed a +12.68% increase.
What is Gongwin Biopham market cap?▼
Today Gongwin Biopham has the market capitalization of 13.71B
What is Gongwin Biopham revenue for the last year?▼
Gongwin Biopham revenue for the last year amounts to 36.45M TWD.
What is Gongwin Biopham net income for the last year?▼
6617.TWO net income for the last year is -114.13M TWD.
How many employees does Gongwin Biopham have?▼
As of November 4, 2026, the company has 20 employees.
In which sector is Gongwin Biopham located?▼
Gongwin Biopham operates in the Health & Wellness sector.
When did Gongwin Biopham complete a stock split?▼
Gongwin Biopham has not had any recent stock splits.
Where is Gongwin Biopham headquartered?▼
Gongwin Biopham is headquartered in Taipei, Taiwan.